Carisbamate vs placebo
50% or greater reduction in seizure frequency · people with drug‐resistant focal epilepsy
Carisbamate probably leads to higher 50% or greater reduction in seizure frequency (responder rate) compared with placebo (moderate certainty).
1 finding from 1 review
- RR 1.36 [1.14, 1.62]4 studies · 2211 participantsModerate